• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login

    • Alzheimers Disease Diagnostic Companies

    ID: MRFR/MED/1597-HCR
    90 Pages
    Rahul Gotadki
    September 2025

    Several companies are actively involved in the development and production of diagnostic tools for Alzheimer's disease. These tools include imaging technologies, blood tests, and other methods for detecting and diagnosing Alzheimer's disease.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Alzheimer’s Disease Diagnostic Market Research Report- Forecast to 2032 Infographic
    Summary Table of Contents Segmentation Infographic

    Top Industry Leaders in the Alzheimers Disease Diagnostic Market

    Alzheimers Disease Diagnostic Companies

     


    Latest Alzheimers Disease Diagnostic Companies Updates:


    Roche Holding AG (Switzerland) Received FDA clearance for its Elecsys Tau and P-tau 181 CSF assays, enabling earlier and more accurate detection of Alzheimer's pathology (Jan 2024).


    Lilly and Company (US) Initiated Phase 3 trial for its investigational blood test, PrecivityAD™, to detect Alzheimer's disease through amyloid and tau protein biomarkers (Dec 2023).


    C2N Diagnostics (US) Completed successful pilot study of its C2N-Tau blood test for early detection of Alzheimer's disease, demonstrating promising results (Nov 2023).Alzheon Announcing positive Phase 2b data for its investigational tau aggregation inhibitor ALZ-801 for the treatment of early Alzheimer's disease (Jan 2024).


    BrainStorm Cell Therapeutics Received FDA Fast Track designation for its NurOwn® stem cell therapy for the treatment of moderate Alzheimer's disease (Dec 2023).


    List of Alzheimers Disease Diagnostic Key companies in the market:




    • Eli Lilly and Company




    • TauRx (Republic of Singapore)




    • Alector LLC




    • Accera, Inc.




    • Treventis Corporation




    • Neuro-Bio Ltd




    • Cognition Therapeutics Inc




    • Hoffmann-La Roche




    • Novartis AG




    • Merck & Co.